Pharmaceutical Compositions
The present invention provides pharmaceutical compositions comprising as an active ingredient candesartan or candesartan cilexetil, compositions exhibiting a relative bioavailability, measured as area under the curve, of more than 1.5.
1 . A pharmaceutical composition comprising as an active ingredient candesartan or candesartan cilexetil, the composition exhibiting a relative bioavailability, measured as area under the curve (AUC), of more than 1.5.
2 . A pharmaceutical composition according to claim 1 wherein the active ingredient is in a substantially non-crystalline form.
3 . A pharmaceutical composition according to claim 1 wherein the composition further comprises a solubilizer.
4 . A pharmaceutical composition according to claim 2 wherein the composition further comprises a solubilizer.
5 . A pharmaceutical composition according to claim 1 wherein the relative bioavailability is more than 2.
6 . A pharmaceutical composition according to claim 2 wherein the relative bioavailability is more than 2.
7 . A pharmaceutical composition according to claim 3 wherein the relative bioavailability is more than 2.
8 . A pharmaceutical composition according to claim 4 wherein the relative bioavailability is more than 2.